DIAGNOSTIC VALUE OF DEFINITION OF FRACTIONS OF PROSTATIC SPECIFIC ANTIGEN AND PROSTATE HEALTH INDEX

DIAGNOSTIC VALUE OF DEFINITION OF FRACTIONS OF PROSTATIC SPECIFIC ANTIGEN AND PROSTATE HEALTH INDEX

OBJECTIVE. The authors investigated the value of comprehensive assessment of clinical and laboratory factors including prostate specific antigen (PSA) fractions and prostate health index (PHI) in diagnostics of prostate cancer. MATERIALS AND METHODS. The study numbered 148 patients who were examined...

Full description

Bibliographic Details
Main Authors:	A. S. Al-Shukri, V. D. Yakovlev, A. G. Boriskin, S. Yu. Borovets, M. A. Rybalov
Format:	Article
Language:	Russian
Published:	Pavlov First Saint Petersburg State Medical University 2017-04-01
Series:	Вестник хирургии имени И.И. Грекова
Subjects:	[-2]пропса prostate cancer diagnostics biopsy [-2]propsa prostate health index
Online Access:	https://www.vestnik-grekova.ru/jour/article/view/317

Similar Items

Diagnostic value of [-2]proPSA and PHI index (review of literature)
by: A. V. Sidorenkov, et al.
Published: (2014-12-01)

APHIG: a new multiparameter index for prostate cancer
by: N. S. Sergeeva, et al.
Published: (2016-12-01)

Diagnostic value of [-2]proPSA and PHI index (review of literature)
by: A. V. Sidorenkov, et al.
Published: (2014-12-01)

Performance of the Prostate Health Index in predicting prostate biopsy outcomes among men with a negative digital rectal examination and transrectal ultrasonography
by: Guo-Peng Yu, et al.
Published: (2016-01-01)

Investigation of correlations between different prostate-specific antigen forms and clinical and morphological characteristics of a tumor process in patients with prostate cancer
by: N. S. Sergeeva, et al.
Published: (2015-06-01)

SIGNIFICANCE OF DOPPLER-GRAPHIC RESEARCHES FOR DIAGNOSTICS OF PROSTATE CANCER
by: A. M. Kurnakov, et al.
Published: (2015-08-01)

Diagnostic value of PCA3, TMPRSS2:ERG and prostatic specific antigen derivatives in the detection of prostate cancer
by: A. A. Musaelyan, et al.
Published: (2020-07-01)

Prostatic specific antigen for prostate cancer detection
by: Lucas Nogueira, et al.
Published: (2009-10-01)

Nonspecific Presentation of a Multiloculated Prostatic Abscess After Transurethral Prostatic Biopsy for Elevated Prostate-specific Antigen Level
by: Nilay M. Gandhi, et al.
Published: (2014-11-01)

What Should Be the Prostate Specific Antigen Threshold for Prostate Biopsy?
by: Hasan Deliktaş, et al.
Published: (2017-06-01)

The results of transrectal prostate biopsy in patients with low levels of prostate specific antigen
by: Ahmet Ali Sancaktutar, et al.
Published: (2012-06-01)

Extended use of Prostate Health Index and percentage of [-2]pro-prostate-specific antigen in Chinese men with prostate specific antigen 10–20 ng/mL and normal digital rectal examination
by: Peter Ka-Fung Chiu, et al.
Published: (2016-09-01)

THE PROGNOSTIC AND DIAGNOSTIC VALUE OF REPEATED TRANSRECTAL PROSTATE SATURATION BIOPSY
by: M. A. Kurdzhiev, et al.
Published: (2014-08-01)

THE PROGNOSTIC AND DIAGNOSTIC VALUE OF REPEATED TRANSRECTAL PROSTATE SATURATION BIOPSY
by: M. A. Kurdzhiev, et al.
Published: (2014-08-01)

Validity of Prostate Health Index and Percentage of [-2] Pro-Prostate-Specific Antigen as Novel Biomarkers in the Diagnosis of Prostate Cancer: Omani Tertiary Hospitals Experience
by: Safana S. Al Saidi, et al.
Published: (2017-07-01)

Is It Effective to Perform Two More Prostate Biopsies According to Prostate-Specific Antigen Level and Prostate Volume in Detecting Prostate Cancer? Prospective Study of 10-Core and 12-Core Prostate Biopsy
by: Byung Il Yoon, et al.
Published: (2012-05-01)

Prostate cancer detection rate in patients with fluctuating prostate-specific antigen levels on the repeat prostate biopsy
by: Yong Hyun Park, et al.
Published: (2014-03-01)

The performance characteristics of prostate-specific antigen and prostate-specific antigen density in Chinese men
by: Jeremy YC Teoh, et al.
Published: (2017-01-01)

Evaluation of the role of digital rectal examination and prostate specific antigen in diagnosis of prostate cancer
by: Harun Çıralık, et al.
Published: (2012-03-01)

Early Prediction of Therapy Response to Abiraterone Acetate Using PSA Subforms in Patients with Castration Resistant Prostate Cancer
by: Katrin Schlack, et al.
Published: (2016-09-01)

Prostatic Inflammation in Prostate Cancer: Protective Effect or Risk Factor?
by: Alessandro Tafuri, et al.
Published: (2021-06-01)

SATURATION BIOPSY OF THE PROSTATE (REVIEW)
by: A. V. Sadchenko, et al.
Published: (2014-07-01)

SATURATION BIOPSY OF THE PROSTATE (REVIEW)
by: A. V. Sadchenko, et al.
Published: (2014-07-01)

Histopathology, pharmacotherapy, and predictors of prostatic malignancy in elderly male patients with raised prostate-specific antigen levels – A prospective study
by: Dhinesh Kumar Mathaiyan, et al.
Published: (2020-01-01)

Indications for a second prostate biopsy in patients suspected with prostate cancer after an initial negative prostate biopsy
by: Kwang Suk Lee, et al.
Published: (2017-03-01)

DIFFERENTIAL DIAGNOSTICS OF PROSTATE TUBERCULOSIS
by: E. V. Brizhatyuk, et al.
Published: (2017-09-01)

Is Prostate Biopsy Recommended in Turkish Men with a Prostate-Specific Antigen Level between 2.5 and 4 ng/mL?
by: Gokhan Koc, MD, et al.
Published: (2017-01-01)

Clinical utility of prostate-specific antigen mass ratio for prediction of prostate cancer detection on a repeated prostate biopsy
by: Won Ki Lee, et al.
Published: (2014-08-01)

CLINICAL SIGNIFICANCE OF BIOMARKERS IN OVARIAN CANCER, PROSTATE CANCER, COLORECTAL CANCER
by: N. V. Marshutina, et al.
Published: (2016-03-01)

Anterior prostate biopsy at initial and repeat evaluation: is it useful to detect significant prostate cancer?
by: Pietro Pepe, et al.
Published: (2015-10-01)

COMPARATIVE EVALUATION OF CURRENT METHODS OF ANESTHESIA IN PERFORMANCE OF TRANSRECTAL PROSTATE BIOPSY
by: M. E. Topuzov, et al.
Published: (2015-10-01)

Percentage of free prostate-specific antigen (PSA) is a useful method in deciding to perform prostate biopsy with higher core numbers in patients with low PSA cut-off values
by: Hasan Yilmaz, et al.
Published: (2015-06-01)

Chronic inflammation of the prostate type IV with respect to risk of prostate cancer
by: Antonio B. Porcaro, et al.
Published: (2014-09-01)

A retrospective comparison between transrectal and transperineal prostate biopsy in the detection of prostate cancer
by: Carmelo Agostino Di Franco, et al.
Published: (2017-03-01)

Serum Adipokines as Predictors for the Outcome of Prostate Biopsies at Early Stage Prostate Cancer Diagnosis
by: Ahmad AE, et al.
Published: (2019-11-01)

Metastasectomy for rectal wall seeding of prostate adenocarcinoma after transrectal prostate biopsy
by: E Matthew DiLizia, et al.
Published: (2021-01-01)

Elevated Prostate Health Index (phi) and Biopsy Reclassification During Active Surveillance of Prostate Cancer
by: Darian Andreas, et al.
Published: (2016-07-01)

Diagnostic Value of Finger-guided Prostate Nodule Biopsy Combined With Systemic Random Biopsy
by: I-Ni Chiang, et al.
Published: (2009-09-01)

External validation of prostate health index-based nomogram for predicting prostate cancer at extended biopsy
by: Stojadinović Milorad M., et al.
Published: (2020-01-01)

Frequency of Adenocarcinoma in Transrectal Ultrasound-guided Prostate Needle Biopsies in Men with Clinical Suspicion of Prostate Cancer and Raised Serum Prostate Specific Antigen
by: Rahma Rashid, et al.
Published: (2013-04-01)

Cannot write session to /tmp/vufind_sessions/sess_kd0hlkccqon87cvn67vbd2eg0d